Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |